Regent Peak Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Regent Peak Wealth Advisors's IBB Position: Q2 2026 in Review
Regent Peak Wealth Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,887 shares worth $359K. The position accounts for 0.07% of the portfolio, ranked #130.
Regent Peak Wealth Advisors first reported a position in IBB in Q4 2019 and has held it in 26 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Regent Peak Wealth Advisors held 1,887 shares of iShares Biotechnology ETF worth $359K as of Q2 2026.
- Regent Peak Wealth Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.07% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #130 holding.
- Regent Peak Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 26 quarters since.
- 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.